Skip to main content
profile image
Selected Works of Walter J. Urba, MD, PhD
Article
P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC: Topic: Multimodality Treatment
Journal of Thoracic Oncology (2017)
  • Rachel Sanborn, Providence Portland Medical Center
  • Brian Boulmay, LSU Health Sciences Center New Orleans
  • Rui Li, Providence Portland Medical Center
  • Kyle Happel, Louisiana State University
  • Sachin Puri, Providence Portland Medical Center
  • Christopher Paustian, Cleveland Clinic
  • Christopher Dubay, Oregon Health & Science University
  • Sandra Aung
  • Brenda Fisher, Providence Portland Medical Center
  • Carlo Bifulco, University of Milan
  • Keith Bahjat, Providence Portland Medical Center
  • Yoshinobu Koguchi, Providence Portland Medical Center
  • Augusto Ochoa, Science Applications International Corporation
  • Hong-Ming Hu, Providence Portland Medical Center
  • Traci Hilton
  • Bernard Fox, Providence Portland Medical Center
  • Walter Urba
Link
Disciplines
Publication Date
January 1, 2017
DOI
10.1016/j.jtho.2016.11.1190
Citation Information
Rachel Sanborn, Brian Boulmay, Rui Li, Kyle Happel, et al.. "P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC: Topic: Multimodality Treatment" Journal of Thoracic Oncology Vol. 12 Iss. 1 (2017)
Available at: http://works.bepress.com/walter-urba/114/